Skip to main content
TipRanks
Go Ultimate75% OFF

Edgewise Therapeutics (EWTX) Ratios

440 Followers

Edgewise Therapeutics Ratios

EWTX's free cash flow for Q3 2026 was $-77.27M. For the 2026 fiscal year, EWTX's free cash flow was decreased by $-17.00K and operating cash flow was $-77.25M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio19.8519.9319.5021.5326.97
Quick Ratio19.8519.9319.5021.5326.97
Cash Ratio2.231.755.131.331.48
Solvency Ratio-5.45-4.77-4.64-3.29-3.92
Operating Cash Flow Ratio-5.25-4.57-5.48-3.17-3.18
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value$ 513.04M$ 447.88M$ 305.79M$ 336.61M$ 272.92M
Leverage Ratios
Debt-to-Assets Ratio0.010.010.020.010.00
Debt-to-Equity Ratio0.010.010.020.010.00
Debt-to-Capital Ratio0.010.010.020.010.00
Long-Term Debt-to-Capital Ratio0.010.000.000.000.00
Financial Leverage Ratio1.061.061.071.061.04
Debt Service Coverage Ratio0.000.000.00-17.700.00
Interest Coverage Ratio0.000.000.00-17.830.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.040.050.080.160.00
Net Debt to EBITDA0.350.280.720.250.36
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT87.66%84.25%87.59%94.39%99.07%
Return on Assets (ROA)-30.36%-27.49%-29.46%-18.43%-15.01%
Return on Equity (ROE)-32.13%-29.14%-31.42%-19.51%-15.60%
Return on Capital Employed (ROCE)-36.44%-34.31%-35.38%-20.44%-15.73%
Return on Invested Capital (ROIC)-36.37%-34.23%-35.27%-20.41%-15.73%
Return on Tangible Assets-30.36%-27.49%-29.46%-18.43%-15.01%
Earnings Yield-6.57%-5.42%-14.37%-14.12%-5.66%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.380.000.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle-967.430.000.000.000.00
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding967.430.000.000.000.00
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-1.40-1.18-1.44-0.98-0.68
Free Cash Flow Per Share-1.40-1.19-1.53-1.09-0.69
Dividend Paid and CapEx Coverage Ratio-561.78-83.10-16.00-9.49-50.16
Capital Expenditure Coverage Ratio-561.78-83.10-16.00-9.49-50.16
Operating Cash Flow Coverage Ratio-36.04-23.02-16.98-11.940.00
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-5.64%-4.47%-14.01%-12.14%-4.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-15.23-18.41-6.96-7.08-17.67
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio4.895.372.191.382.76
Price-to-Free Cash Flow (P/FCF) Ratio-17.73-22.36-7.14-8.24-22.13
Price-to-Operating Cash Flow Ratio-17.76-22.63-7.58-9.10-22.57
Price-to-Earnings Growth (PEG) Ratio-1.232.41-0.28-0.15-0.12
Enterprise Value Multiple-15.09-18.48-5.47-6.49-17.25
Enterprise Value2.50B2.43B616.45M461.54M740.80M
EV to EBITDA-15.09-18.48-5.47-6.49-17.25
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-17.34-22.03-6.31-7.93-21.68
EV to Operating Cash Flow-17.37-22.29-6.70-8.77-22.11
Tangible Book Value Per Share5.074.975.006.475.54
Shareholders’ Equity Per Share5.074.975.006.475.54
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-1.63-1.45-1.57-1.26-0.86
Tax Burden1.001.001.001.001.00
Interest Burden1.001.000.880.940.99
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.860.810.920.780.78

Currency in USD